Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
WuXi AppTec hosted an inaugural Global Monoclonal Antibody Summit in conjunction with the startup of its cGMP biologics manufacturing facility in the city of Wuxi on October 10-12, 2012. Attending the event were executives from global pharmaceutical ...
read more
Wednesday, April 25, 2018
WuXi AppTec announced the opening of its expanded Laboratory Testing Division facility in New Jersey.
read more
Monday, December 10, 2018
WuXi AppTec announces the expansion of its facilities in San Diego, California.
read more
Thursday, October 30, 2025
WuXi AppTec has reached a definitive agreement to sell its China-based clinical research services subsidiaries, WuXi Clinical and WuXi MedKey, to Hillhouse Investment Management, a global private asset manager.
read more
Wednesday, March 03, 2021
WuXi AppTec has completed the acquisition of OXGENE, a UK-based contract research and development organization that designs and develops scalable gene therapy technologies.
read more
WuXi AppTec announced it has acquired Pharmapace, a US-based clinical research services company with expertise of providing high quality biometrics services.
read more
WuXi AppTec, a global pharmaceutical, biotechnology and medical device open-access capability and technology platform, has acquired HD Biosciences (HDB), a biology focused preclinical drug discovery contract research organization (CRO).
read more
WuXi AppTec, an open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, has acquired Crelux GmbH, a structure based drug discovery provider based in Munich, Germany.
read more
WPD has entered into a development agreement with CNS for the development of several preclinical drug candidates including WP1122, which will be tested on a range of viruses including the coronavirus SARS-CoV-2.
read more
WPD announced independent research on WP1122 drug compound found 2-DG to reduce replication of SARS-CoV-2 by 100% in in vitro testing.
read more
Friday, September 15, 2023
Worldwide Clinical Trials, a full-service contract research organization (CRO), announced its Early Phase Clinical Pharmacology Unit (CPU) has been awarded accreditation from the College of American Pathologists (CAP).
read more
Worldwide Clinical Trials will host a free webinar, titled “Are We Moving Toward ‘Siteless’ Clinical Trials? Exploring the Current and Future Potential of Home-Based Studies,” on Thursday, July 14, 2016 at 11 am ET. Leading the discussion will be ...
read more
Tuesday, January 20, 2026
Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a specialized oncology CRO, known for early phase oncology trials and a strong biometrics and its Functional Service Provider (FSP) model.
read more
Worldwide Clinical Trials has selected Medidata Payments Cloud to streamline accurate, timely payments on behalf of their clinical trial sponsors.
read more
BrainStorm Cell Therapeutics has selected Worldwide Clinical Trials as its Clinical Research Organization for its planned Phase 3 study of NurOwn in the treatment of ALS.
read more